Ad Monsters

JANUARY 28, 2024

Well, another year around the sun, and data privacy is still a hot topic in ad tech. With cookie deprecation finally here, how could it not be? Whether ad tech is thinking about testing the Privacy Sandbox or alternative IDs, or even the lack of federal privacy regulations — data privacy remains a hot topic for the industry.

Pharmaceuticals 114

Pharmaceuticals Ad Tech Healthcare Audience 114

Digiday

MAY 29, 2022

We talk about QSR for obvious reasons, but we also have the ‘do it yourself’ Home Depot shopper, and people and that are much more focused on sustainability” as well health-conscious consumers who are looking to avoid mainstream pharmaceutical products, he said. We follow them across over 900,000 retail locations in the U.S.,” Speed reading.

Media 85

Media Advertising Pharmaceuticals Marketing 85

VideoWeek

MAY 19, 2023

Google says Privacy Sandbox Tools are Nearly Finished; Outlines Testing Plans Google this week released an update on progress within its Privacy Sandbox, its initiative for developing replacements for third-party cookies within its Chrome browser.

Cookies 52

Cookies Non-Profit Agency Media 52

VideoWeek

APRIL 21, 2023

Google Releases Results for Cookie-Free Campaign Tests Google released a new set of results this week testing the performance of cookie-free campaigns, compared with campaigns which use third-party cookies. Google found that advertiser spend, as a proxy for reach, was down y 2-7 percent compared with cookie-based targeting.

Agency 52

Agency Media Audience Cookies 52

Clearcode

MAY 10, 2023

We also work with numerous pharmaceutical companies on market share data inside the data clean room. That’s what we tend to see as well, and that’s why we’re trusted by pharmaceutical companies, insurance companies, banks, and other highly sensitive data owners. And they will always ask questions.

Advertising 52

Advertising Pharmaceuticals Media GDPR 52

VideoWeek

DECEMBER 6, 2024

Restrictions on pharmaceutical ads look likely, says Madison and Wall’s CEO, CFA and principal Brian Wieser. And this would hit TV particularly hard, since pharmaceutical companies invest heavily in TV. Kennedy as his health secretary. M&W forecasts a 6.1

Advertising 52

Advertising Retail Pharmaceuticals Media 52